Health
Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19 – PRNewswire
/PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind……
ZURICH, March 23, 2021 /PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms.
While other studies to date (including the COVI-GAPP study Ava announced in April 2020
) have examined the feasibility of using machine learning and wearable devices…
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General21 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business22 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock